Yun Jeong Lee

Tirzepatide for Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Reductions in Hypoxic Burden and Cardiometabolic Risk Markers

Obesity is a major modifiable driver of obstructive sleep apnea (OSA), contributing to upper-airway obstruction, nocturnal hypoxemia, and cardiometabolic burden.Tirzepatide, a dual glucose-dependent insulinotropic polypeptide receptor/ glucagon-like peptide-1 receptor agonist, of...